What is the recommended dose of Metronidazole (Flagyl) intravenous (IV) for pediatric patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Metronidazole IV Dosing for Pediatric Patients

The recommended intravenous dose of metronidazole for pediatric patients is 30-40 mg/kg/day divided every 8 hours, with a maximum of 500 mg per dose. 1, 2

Standard Dosing Regimen

For most pediatric infections requiring anaerobic coverage, administer 30-40 mg/kg/day divided into three doses (every 8 hours), not exceeding 500 mg per individual dose. 1, 2

  • This dosing applies to children beyond the neonatal period and is the guideline-recommended regimen from the Infectious Diseases Society of America for complicated intra-abdominal infections 1
  • The typical duration of therapy is 10 days for most infections 2

Neonatal Dosing (Age and Weight-Specific)

Neonates require significantly different dosing based on postnatal age and weight due to immature drug elimination pathways 2, 3:

  • Postnatal age ≤7 days and weight ≤2000 g: 7.5 mg/kg every 12 hours 2
  • Postnatal age ≤7 days and weight >2000 g: 7.5-10 mg/kg every 12 hours 2
  • Postnatal age >7 days and weight <1200 g: 7.5-10 mg/kg every 8-12 hours 2
  • Postnatal age >7 days and weight >2000 g: 10 mg/kg every 8 hours 2

Condition-Specific Dosing Variations

Complicated Intra-Abdominal Infections

  • Use 30-40 mg/kg/day divided every 8 hours as part of combination therapy with aminoglycosides, carbapenems, or advanced-generation cephalosporins 1, 2
  • For severe infections with undrained abscesses, maximize dosing within the recommended range (closer to 40 mg/kg/day) 1

Clostridium difficile Infection (CDI)

Critical dosing difference: CDI requires LOWER doses than other anaerobic infections 2:

  • Non-severe CDI: 7.5 mg/kg/dose three or four times daily (maximum 500 mg per dose) for 10 days 2
  • Severe CDI requiring IV therapy: 10 mg/kg/dose three times daily (maximum 500 mg per dose) 2

Necrotizing Infections with Anaerobic Coverage

  • Use 7.5 mg/kg/dose every 6 hours IV, typically combined with cefotaxime (50 mg/kg/dose every 6 hours) or other broad-spectrum agents 2

Perianal Crohn's Disease

  • Use 10-20 mg/kg/day in divided doses 2

Important Clinical Considerations

Dosing Frequency

Recent pharmacokinetic data demonstrates that once-daily dosing (30 mg/kg/dose) achieves adequate AUC/MIC ratios for Bacteroides fragilis with MIC ≤2 mcg/mL in pediatric appendicitis patients 4. However, the established guideline recommendation remains every 8 hours dosing for most infections 1, 2, and this should be followed in standard practice until further evidence supports widespread adoption of once-daily dosing.

Special Populations

  • Malnourished children: Require dose reduction to approximately 12 mg/kg/day (60% reduction from standard dosing) due to impaired drug clearance 5
  • Monitor for drug accumulation in severely malnourished patients as biotransformation is significantly affected 5

Maximum Dose Limits

  • Individual doses should not exceed 500 mg regardless of calculated weight-based dose 2
  • This ceiling prevents excessive drug exposure while maintaining therapeutic efficacy 2

Common Pitfalls to Avoid

  • Do not simply scale adult doses by weight alone - this results in underdosing in infants/children and overdosing in neonates due to differences in drug elimination that are not proportional to weight 3
  • Do not use the same dose for CDI as for other anaerobic infections - CDI requires lower dosing (7.5 mg/kg/dose vs 10-13 mg/kg/dose) 2
  • Do not forget the 500 mg per dose maximum - even in larger adolescents, individual doses should be capped 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Pediatric Metronidazole Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

A new dosing regimen for metronidazole in malnourished children.

Scandinavian journal of infectious diseases, 1993

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.